CRBU
Price
$1.11
Change
-$0.05 (-4.31%)
Updated
Jun 13 closing price
Capitalization
103.24M
59 days until earnings call
CRSP
Price
$41.36
Change
+$0.08 (+0.19%)
Updated
Jun 13 closing price
Capitalization
3.57B
58 days until earnings call
Interact to see
Advertisement

CRBU vs CRSP

Header iconCRBU vs CRSP Comparison
Open Charts CRBU vs CRSPBanner chart's image
Caribou Biosciences
Price$1.11
Change-$0.05 (-4.31%)
Volume$1.16M
Capitalization103.24M
CRISPR Therapeutics AG
Price$41.36
Change+$0.08 (+0.19%)
Volume$2.02M
Capitalization3.57B
CRBU vs CRSP Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. CRSP commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and CRSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (CRBU: $1.11 vs. CRSP: $41.36)
Brand notoriety: CRBU and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 109% vs. CRSP: 93%
Market capitalization -- CRBU: $103.24M vs. CRSP: $3.57B
CRBU [@Biotechnology] is valued at $103.24M. CRSP’s [@Biotechnology] market capitalization is $3.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 6 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 5 bearish.
  • CRSP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -11.90% price change this week, while CRSP (@Biotechnology) price change was -1.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.57B) has a higher market cap than CRBU($103M). CRSP YTD gains are higher at: 5.081 vs. CRBU (-30.189). CRBU has higher annual earnings (EBITDA): -159.14M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. CRBU (208M). CRBU has less debt than CRSP: CRBU (26.2M) vs CRSP (219M). CRSP has higher revenues than CRBU: CRSP (35M) vs CRBU (9.92M).
CRBUCRSPCRBU / CRSP
Capitalization103M3.57B3%
EBITDA-159.14M-455.24M35%
Gain YTD-30.1895.081-594%
P/E RatioN/AN/A-
Revenue9.92M35M28%
Total Cash208M1.86B11%
Total Debt26.2M219M12%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUCRSP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OUKPY6.280.17
+2.78%
Metso OYJ
BSRTF13.190.14
+1.07%
Bsr Real Estate Invt Tr
SAXPY20.92-0.29
-1.37%
Sampo OYJ
ATLKY16.08-0.29
-1.77%
Atlas Copco AB
PEMIF0.15-0.01
-5.50%
Pure Energy Minerals Ltd.

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-4.31%
CRSP - CRBU
61%
Loosely correlated
+0.19%
FATE - CRBU
58%
Loosely correlated
-8.93%
CCCC - CRBU
57%
Loosely correlated
+3.70%
BEAM - CRBU
55%
Loosely correlated
-2.18%
MGNX - CRBU
53%
Loosely correlated
-1.94%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+0.19%
RXRX - CRSP
73%
Closely correlated
-4.84%
BEAM - CRSP
72%
Closely correlated
-2.18%
NTLA - CRSP
66%
Loosely correlated
-0.48%
PRME - CRSP
64%
Loosely correlated
N/A
ALLO - CRSP
61%
Loosely correlated
-4.29%
More